Europe's Last Chance To Revive Its Pharmaceutical Innovation Power
Source: SeekingAlpha
2026-03-19 21:10:00 ET
By Diederik Stadig , Senior Economist, Healthcare & Technology
Why price, manufacturing and innovation are so intertwined for pharma
Europe’s pharmaceutical industry needs to make sure it doesn't become yesterday's news. Its biopharmaceutical innovation capacity has been gradually declining for decades, and the rapid ascent of China and President Trump's policies risk accelerating that decay. It still has good cards to play but needs to act fast...
Read the full article on Seeking Alpha
For further details see:
Europe's Last Chance To Revive Its Pharmaceutical Innovation Power
iShares U.S. Pharmaceutical
NASDAQ: IHE
IHE Trading
-0.66% G/L:
$84.115 Last:
18,025 Volume:
$84.86 Open:
